Clinical Trials · NCT05078255
The Separate and Combined Effects of Long-term GIP and GLP-1 Receptor Activation in Patients with Type 2 Diabetes
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Asger Lund, MD
- Enrollment
- 61
- Start date
- Jan 2022
- Locations
- 1 site, Denmark
- Primary endpoint
- Mean glucose levels (assessed by blinded continuous glucose monitoring (CGM))